Abstract without limitations n (%) | Abstract with limitations n (%) | Total n (%) | ||
---|---|---|---|---|
N = 150 | N = 150 | N = 300 | ||
Qualification | MD | 78 (52.0) | 78 (52.0) | 156 (52.0) |
PhD | 58 (38.7) | 64 (42.7) | 122 (40.7) | |
Other | 14 (9.3) | 8 (5.3) | 22 (7.3) | |
Clinical experience | <5 years | 6 (4.0) | 8 (5.3) | 14 (4.7) |
5 to 10 years | 34 (22.7) | 28 (18.7) | 62 (20.7) | |
>10 years | 110 (73.3) | 114 (76.6) | 224 (74.7) | |
Reading reports of systematic reviews | Rarely or sometimes | 61 (40.7) | 62 (41.6) | 123 (41.1) |
Regularly | 89 (59.3) | 87 (58.4) | 176 (58.9) | |
No. of randomized trials involved in | 0 | 16 (10.7) | 11 (7.3) | 27 (9.0) |
1–3 | 48 (32.0) | 48 (32.0) | 96 (32.0) | |
4–9 | 45 (30) | 54 (36.0) | 99 (33.0) | |
>10 | 41 (27.3) | 37 (24.7) | 78 (26.0) | |
Authored at least one systematic review | 77 (51.3) | 82 (55.0) | 159 (53.2) | |
No. of systematic reviews peer-reviewed | 0 | 75 (50.0) | 64 (43.0) | 139 (46.5) |
1–3 | 55 (36.7) | 69 (46.3) | 124 (41.5) | |
>3 | 20 (13.3) | 16 (10.7) | 36 (12.0) | |
Training in clinical epidemiology | 101 (67.3) | 76 (50.7) | 177 (59.0) | |
Training in methods of randomized trials | 86 (57.3) | 71 (47.3) | 157 (52.3) |